| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 611.639.162 $ | 99,50 | 7.469.660 | |||||||
| Eli Lilly & Co | Eli Lilly & Co | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 73.792.278 $ | 12,00 | 78.956 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 44.348.868 $ | 7,21 | 192.947 | |
| AbbVie Inc | AbbVie Inc | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 36.074.437 $ | 5,87 | 170.710 | |
| Merck & Co Inc | Merck & Co Inc | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 26.839.719 $ | 4,37 | 245.830 | |
| Gilead Sciences Inc | Gilead Sciences Inc | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 24.152.541 $ | 3,93 | 184.596 | |
| UnitedHealth Group Inc | UnitedHealth Group Inc | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 23.074.976 $ | 3,75 | 62.284 | |
| Novartis AG | Novartis AG | EC | CH0012005267 | Long | Modellwert (Stufe 2) | 18.358.728 $ | 2,99 | 124.222 | |
| Medtronic PLC | Medtronic PLC | EC | IE00BTN1Y115 | Long | Börsenkurs (Stufe 1) | 16.622.736 $ | 2,70 | 205.295 | |
| Stryker Corp | Stryker Corp | EC | 863667101 | Long | Börsenkurs (Stufe 1) | 16.156.715 $ | 2,63 | 51.270 | |
| Amgen Inc | Amgen Inc | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 16.142.521 $ | 2,63 | 46.621 | |
| Roche Holding AG | Roche Holding AG | EC | CH1499059983 | Long | Modellwert (Stufe 2) | 14.632.912 $ | 2,38 | 35.909 | |
| GSK PLC | GSK PLC | EC | GB00BN7SWP63 | Long | Modellwert (Stufe 2) | 13.156.607 $ | 2,14 | 501.826 | |
| AstraZeneca PLC | AstraZeneca PLC | EC | GB0009895292 | Long | Modellwert (Stufe 2) | 11.838.286 $ | 1,93 | 62.398 | |
| Thermo Fisher Scientific Inc | Thermo Fisher Scientific Inc | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 11.546.768 $ | 1,88 | 24.108 | |
| Cigna Group/The | Cigna Group/The | EC | 125523100 | Long | Börsenkurs (Stufe 1) | 11.441.588 $ | 1,86 | 39.375 | |
| Boston Scientific Corp | Boston Scientific Corp | EC | 101137107 | Long | Börsenkurs (Stufe 1) | 11.234.814 $ | 1,83 | 195.015 | |
| Regeneron Pharmaceuticals Inc | Regeneron Pharmaceuticals Inc | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 10.565.598 $ | 1,72 | 14.943 | |
| Vertex Pharmaceuticals Inc | Vertex Pharmaceuticals Inc | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 10.282.335 $ | 1,67 | 24.059 | |
| McKesson Corp | McKesson Corp | EC | 58155Q103 | Long | Börsenkurs (Stufe 1) | 9.246.814 $ | 1,50 | 11.343 | |
| GE HealthCare Technologies Inc | GE HealthCare Technologies Inc | EC | 36266G107 | Long | Börsenkurs (Stufe 1) | 9.174.733 $ | 1,49 | 150.801 | |
| HCA Healthcare Inc | HCA Healthcare Inc | EC | 40412C101 | Long | Börsenkurs (Stufe 1) | 8.249.337 $ | 1,34 | 18.988 | |
| Astellas Pharma Inc | Astellas Pharma Inc | EC | JP3942400007 | Long | Modellwert (Stufe 2) | 8.073.642 $ | 1,31 | 569.700 | |
| Bristol-Myers Squibb Co | Bristol-Myers Squibb Co | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 7.374.712 $ | 1,20 | 121.715 | |
| STERIS PLC | STERIS PLC | EC | IE00BFY8C754 | Long | Börsenkurs (Stufe 1) | 7.244.226 $ | 1,18 | 33.402 | |
| Exelixis Inc | Exelixis Inc | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 7.062.560 $ | 1,15 | 158.852 | |
| Cardinal Health Inc | Cardinal Health Inc | EC | 14149Y108 | Long | Börsenkurs (Stufe 1) | 6.993.057 $ | 1,14 | 36.256 | |
| Ipsen SA | Ipsen SA | EC | FR0010259150 | Long | Modellwert (Stufe 2) | 6.912.357 $ | 1,12 | 35.195 | |
| Becton Dickinson & Co | Becton Dickinson & Co | EC | 075887109 | Long | Börsenkurs (Stufe 1) | 6.539.279 $ | 1,06 | 43.876 | |
| United Therapeutics Corp | United Therapeutics Corp | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 6.468.825 $ | 1,05 | 11.322 | |
| Danaher Corp | Danaher Corp | EC | 235851102 | Long | Börsenkurs (Stufe 1) | 6.243.029 $ | 1,02 | 34.887 | |
| Abbott Laboratories | Abbott Laboratories | EC | 002824100 | Long | Börsenkurs (Stufe 1) | 6.203.771 $ | 1,01 | 68.331 | |
| HealthEquity Inc | HealthEquity Inc | EC | 42226A107 | Long | Börsenkurs (Stufe 1) | 6.125.836 $ | 1,00 | 74.678 | |
| Hoya Corp | Hoya Corp | EC | JP3837800006 | Long | Modellwert (Stufe 2) | 5.789.056 $ | 0,94 | 31.000 | |
| IQVIA Holdings Inc | IQVIA Holdings Inc | EC | 46266C105 | Long | Börsenkurs (Stufe 1) | 5.391.073 $ | 0,88 | 34.041 | |
| ResMed Inc | ResMed Inc | EC | 761152107 | Long | Börsenkurs (Stufe 1) | 5.364.921 $ | 0,87 | 25.092 | |
| Sanofi SA | Sanofi SA | EC | FR0000120578 | Long | Modellwert (Stufe 2) | 4.990.151 $ | 0,81 | 53.327 | |
| Incyte Corp | Incyte Corp | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 4.924.125 $ | 0,80 | 51.686 | |
| Agilent Technologies Inc | Agilent Technologies Inc | EC | 00846U101 | Long | Börsenkurs (Stufe 1) | 4.905.675 $ | 0,80 | 42.455 | |
| IDEXX Laboratories Inc | IDEXX Laboratories Inc | EC | 45168D104 | Long | Börsenkurs (Stufe 1) | 4.899.149 $ | 0,80 | 8.736 | |
| BrightSpring Health Services Inc | BrightSpring Health Services Inc | EC | 10950A106 | Long | Börsenkurs (Stufe 1) | 4.532.254 $ | 0,74 | 94.481 | |
| Prestige Consumer Healthcare Inc | Prestige Consumer Healthcare Inc | EC | 74112D101 | Long | Börsenkurs (Stufe 1) | 4.233.462 $ | 0,69 | 75.168 | |
| Veracyte Inc | Veracyte Inc | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 3.758.312 $ | 0,61 | 114.165 | |
| Natera Inc | Natera Inc | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 3.695.418 $ | 0,60 | 17.925 | |
| Koninklijke Philips NV | Koninklijke Philips NV | EC | NL0000009538 | Long | Modellwert (Stufe 2) | 3.681.650 $ | 0,60 | 139.574 | |
| ANI Pharmaceuticals Inc | ANI Pharmaceuticals Inc | EC | 00182C103 | Long | Börsenkurs (Stufe 1) | 3.449.719 $ | 0,56 | 43.420 | |
| Smith & Nephew PLC | Smith & Nephew PLC | EC | GB0009223206 | Long | Modellwert (Stufe 2) | 3.402.088 $ | 0,55 | 219.861 | |
| Intuitive Surgical Inc | Intuitive Surgical Inc | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 3.272.827 $ | 0,53 | 7.152 | |
| Innoviva Inc | Innoviva Inc | EC | 45781M101 | Long | Börsenkurs (Stufe 1) | 3.028.864 $ | 0,49 | 131.747 | |
| Ensign Group Inc/The | Ensign Group Inc/The | EC | 29358P101 | Long | Börsenkurs (Stufe 1) | 2.890.521 $ | 0,47 | 15.483 | |
| Catalyst Pharmaceuticals Inc | Catalyst Pharmaceuticals Inc | EC | 14888U101 | Long | Börsenkurs (Stufe 1) | 2.573.698 $ | 0,42 | 91.493 | |
| Consun Pharmaceutical Group Ltd | Consun Pharmaceutical Group Ltd | EC | KYG2524A1031 | Long | Modellwert (Stufe 2) | 2.264.861 $ | 0,37 | 1.093.000 | |
| Shionogi & Co Ltd | Shionogi & Co Ltd | EC | JP3347200002 | Long | Modellwert (Stufe 2) | 2.232.424 $ | 0,36 | 110.500 | |
| Axsome Therapeutics Inc | Axsome Therapeutics Inc | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 2.010.605 $ | 0,33 | 9.678 | |
| Mettler-Toledo International Inc | Mettler-Toledo International Inc | EC | 592688105 | Long | Börsenkurs (Stufe 1) | 1.914.915 $ | 0,31 | 1.500 | |
| UCB SA | UCB SA | EC | BE0003739530 | Long | Modellwert (Stufe 2) | 1.845.318 $ | 0,30 | 6.777 | |
| Biogen Inc | Biogen Inc | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 1.747.433 $ | 0,28 | 9.232 | |
| Fisher & Paykel Healthcare Corp Ltd | Fisher & Paykel Healthcare Corp Ltd | EC | NZFAPE0001S2 | Long | Modellwert (Stufe 2) | 1.624.933 $ | 0,26 | 75.402 | |
| BioCryst Pharmaceuticals Inc | BioCryst Pharmaceuticals Inc | EC | 09058V103 | Long | Börsenkurs (Stufe 1) | 1.611.244 $ | 0,26 | 175.900 | |
| Zoetis Inc | Zoetis Inc | EC | 98978V103 | Long | Börsenkurs (Stufe 1) | 1.512.315 $ | 0,25 | 13.154 | |
| Samsung Biologics Co Ltd | Samsung Biologics Co Ltd | EC | KR7207940008 | Long | Modellwert (Stufe 2) | 1.508.520 $ | 0,25 | 1.513 | |
| Chugai Pharmaceutical Co Ltd | Chugai Pharmaceutical Co Ltd | EC | JP3519400000 | Long | Modellwert (Stufe 2) | 1.493.222 $ | 0,24 | 28.000 | |
| Asahi Intecc Co Ltd | Asahi Intecc Co Ltd | EC | JP3110650003 | Long | Modellwert (Stufe 2) | 1.470.876 $ | 0,24 | 69.900 | |
| Mirum Pharmaceuticals Inc | Mirum Pharmaceuticals Inc | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 1.433.863 $ | 0,23 | 14.735 | |
| Ambea AB | Ambea AB | EC | SE0009663826 | Long | Börsenkurs (Stufe 1) | 1.433.329 $ | 0,23 | 94.458 | |
| 10X Genomics Inc | 10X Genomics Inc | EC | 88025U109 | Long | Börsenkurs (Stufe 1) | 1.428.245 $ | 0,23 | 64.773 | |
| BioMarin Pharmaceutical Inc | BioMarin Pharmaceutical Inc | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 1.426.782 $ | 0,23 | 26.466 | |
| Madrigal Pharmaceuticals Inc | Madrigal Pharmaceuticals Inc | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 1.395.918 $ | 0,23 | 2.698 | |
| Elevance Health Inc | Elevance Health Inc | EC | 036752103 | Long | Börsenkurs (Stufe 1) | 1.382.591 $ | 0,22 | 3.673 | |
| Merit Medical Systems Inc | Merit Medical Systems Inc | EC | 589889104 | Long | Börsenkurs (Stufe 1) | 1.343.146 $ | 0,22 | 19.700 | |
| Jazz Pharmaceuticals PLC | Jazz Pharmaceuticals PLC | EC | IE00B4Q5ZN47 | Long | Börsenkurs (Stufe 1) | 1.294.253 $ | 0,21 | 6.375 | |
| Novo Nordisk A/S | Novo Nordisk A/S | EC | DK0062498333 | Long | Modellwert (Stufe 2) | 1.269.825 $ | 0,21 | 29.853 | |
| DENTSPLY SIRONA Inc | DENTSPLY SIRONA Inc | EC | 24906P109 | Long | Börsenkurs (Stufe 1) | 1.191.145 $ | 0,19 | 101.374 | |
| Aurinia Pharmaceuticals Inc | Aurinia Pharmaceuticals Inc | EC | 05156V102 | Long | Börsenkurs (Stufe 1) | 1.155.414 $ | 0,19 | 75.100 | |
| Pfizer Inc | Pfizer Inc | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 1.152.906 $ | 0,19 | 43.180 | |
| Convatec Group PLC | Convatec Group PLC | EC | GB00BD3VFW73 | Long | Modellwert (Stufe 2) | 862.363 $ | 0,14 | 300.703 | |
| Medpace Holdings Inc | Medpace Holdings Inc | EC | 58506Q109 | Long | Börsenkurs (Stufe 1) | 820.574 $ | 0,13 | 1.960 | |
| Neurocrine Biosciences Inc | Neurocrine Biosciences Inc | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 816.354 $ | 0,13 | 6.200 | |
| AnaptysBio Inc | AnaptysBio Inc | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 784.750 $ | 0,13 | 11.939 | |
| Maximus Inc | Maximus Inc | EC | 577933104 | Long | Börsenkurs (Stufe 1) | 761.192 $ | 0,12 | 11.600 | |
| Galenica AG | Galenica AG | EC | CH0360674466 | Long | Börsenkurs (Stufe 1) | 743.267 $ | 0,12 | 6.976 | |
| Amneal Pharmaceuticals Inc | Amneal Pharmaceuticals Inc | EC | 03168L105 | Long | Börsenkurs (Stufe 1) | 654.620 $ | 0,11 | 50.864 | |
| Hugel Inc | Hugel Inc | EC | KR7145020004 | Long | Modellwert (Stufe 2) | 649.010 $ | 0,11 | 3.776 | |
| Bridgebio Pharma Inc | Bridgebio Pharma Inc | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 617.377 $ | 0,10 | 8.682 | |
| Xeris Biopharma Holdings Inc | Xeris Biopharma Holdings Inc | EC | 98422E103 | Long | Börsenkurs (Stufe 1) | 313.851 $ | 0,05 | 51.241 | |
| Elekta AB | Elekta AB | EC | SE0000163628 | Long | Modellwert (Stufe 2) | 290.171 $ | 0,05 | 49.962 | |
| Livzon Pharmaceutical Group Inc | Livzon Pharmaceutical Group Inc | EC | CNE100001QV5 | Long | Börsenkurs (Stufe 1) | 223.986 $ | 0,04 | 62.300 | |
| 611.639.162 $ | 99,50 | 7.469.660 |